Bull­ish Amarin dou­bling sales force in fast run-up to the big FDA de­ci­sion on Vas­cepa

Amarin is hir­ing. And that will like­ly get the buzz about this biotech’s near-term fu­ture back in play.

In a state­ment out ear­ly Tues­day, Amarin ex­ecs said they plan to go ahead and get start­ed dou­bling the sales force, re­cruit­ing hun­dreds of new staffers as they gear up for the much-an­tic­i­pat­ed re-launch of Vas­cepa with a block­buster la­bel rewrite hang­ing at the FDA.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.